PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.89%
Revenue growth under 50% of TSM's 10.58%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
5.98%
Gross profit growth at 50-75% of TSM's 10.85%. Martin Whitman would question if cost structure or brand is lagging.
13.25%
EBIT growth similar to TSM's 12.64%. Walter Schloss might infer both firms share similar operational efficiencies.
13.25%
Operating income growth similar to TSM's 12.64%. Walter Schloss would assume both share comparable operational structures.
17.62%
Net income growth comparable to TSM's 18.01%. Walter Schloss might see both following similar market or cost trajectories.
15.87%
EPS growth at 75-90% of TSM's 18.01%. Bill Ackman would push for improved profitability or share repurchases to catch up.
15.87%
Diluted EPS growth at 75-90% of TSM's 18.01%. Bill Ackman would expect further improvements in net income or share count reduction.
0.95%
Share count expansion well above TSM's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.06%
Reduced diluted shares while TSM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
197.99%
OCF growth above 1.5x TSM's 9.52%. David Dodd would confirm a clear edge in underlying cash generation.
249.90%
Positive FCF growth while TSM is negative. John Neff would see a strong competitive edge in net cash generation.
104.85%
10Y revenue/share CAGR under 50% of TSM's 251.99%. Michael Burry would suspect a lasting competitive disadvantage.
13.16%
5Y revenue/share CAGR under 50% of TSM's 65.47%. Michael Burry would suspect a significant competitive gap or product weakness.
6.40%
3Y revenue/share CAGR under 50% of TSM's 60.59%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
793.32%
OCF/share CAGR of 793.32% while TSM is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-26.42%
Negative 5Y OCF/share CAGR while TSM is at 59.26%. Joel Greenblatt would question the firm’s operational model or cost structure.
409.15%
3Y OCF/share CAGR above 1.5x TSM's 67.63%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
183.95%
Below 50% of TSM's 822.44%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
45.78%
5Y net income/share CAGR at 50-75% of TSM's 69.09%. Martin Whitman might see a shortfall in operational efficiency or brand power.
158.63%
3Y net income/share CAGR above 1.5x TSM's 64.96%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
362.88%
Equity/share CAGR of 362.88% while TSM is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
87.50%
5Y equity/share CAGR above 1.5x TSM's 38.79%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
43.12%
3Y equity/share CAGR at 75-90% of TSM's 48.73%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.59%
Firm’s AR is declining while TSM shows 4.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-11.69%
Inventory is declining while TSM stands at 8.02%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.57%
Positive asset growth while TSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
6.68%
75-90% of TSM's 7.47%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-2.42%
We’re deleveraging while TSM stands at 57.58%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
3.54%
R&D growth drastically higher vs. TSM's 5.84%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.39%
We cut SG&A while TSM invests at 4.46%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.